Annual report pursuant to Section 13 and 15(d)

SEGMENT INFORMATION (Details)

v3.22.1
SEGMENT INFORMATION (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2021
USD ($)
segment
Dec. 31, 2020
USD ($)
Segment Reporting Information [Line Items]    
Number of operating segments | segment 2  
Product sales, net $ 20,048 $ 24,429
Gross profit 8,616 11,009
Research and development 1,185 2,943
Selling, general and administrative 25,877 30,658
Operating loss (18,446) (22,592)
Goodwill 0 2,788
Consumer Products Segment    
Segment Reporting Information [Line Items]    
Product sales, net 20,048 24,429
Gross profit 8,616 11,009
Research and development 492 678
Selling, general and administrative 20,783 30,547
Operating loss (12,659) (20,216)
Specialty Pharmaceutical Segment    
Segment Reporting Information [Line Items]    
Product sales, net 0 0
Gross profit 0 0
Research and development 693 2,265
Selling, general and administrative 5,094 111
Operating loss (5,787) (2,376)
Intangible assets $ 1,500 3,700
Goodwill   $ 2,800